OCL: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue
What it covers
Surgical device for cutting, coagulation, and/or ablation of tissue, including cardiac tissue
FDA’s definition of product code OCL, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K252056 | Isolator® Synergy EnCompass Clamp and Guide system (OLH, OSH, GPM100) | AtriCure, Inc. | Jul 24, 2025 | Special |
| K234151 | Isolator Synergy EnCapture Ablation System (EMH) | AtriCure, Inc. | Aug 27, 2024 | Traditional |
| K221358 | Isolator® Linear Pen (MLP1); Isolator® Transpolar Pen (MAX1, MAX5), Coolrail® Linear Pen (MCR1); Isolator® Synergy Surgical Ablation System (EMR2, EML2); Isolator® Synergy EnCompass Clamp (OLH, OSH) and Guide System; Isolator® Synergy Access Clamp (EMT1) | AtriCure, Inc. | Dec 30, 2022 | Traditional |
| K223508 | Cardioblate Gemini-s 49260 Surgical Ablation Device; Cardioblate Gemini-s 49351 Surgical Ablation Device | Medtronic, Inc. | Dec 22, 2022 | Special |
| K210477 | AtriCure Isolator Encompass Ablation System, GLIDEPATH Magnetic GUIDE | AtriCure, Inc. | Jul 26, 2021 | Traditional |
| K211311 | AtriCure Isolator® Synergy Surgical Ablation System | AtriCure, Inc. | May 28, 2021 | Special |
| K200514 | Cardioblate Gemini-s Surgical Ablation Device | Medtronic | Jun 3, 2020 | Traditional |
| K193162 | EPi-Sense Guided Coagulation System with VisiTrax | AtriCure, Inc. | Dec 13, 2019 | Special |
| K192125 | Isolator Transpolar Pen, Isolator Long Pen TT, Isolator Linear Pen | AtriCure, Inc. | Nov 4, 2019 | Special |
| K191526 | Cardioblate CryoFlex Surgical Ablation System | Medtronic, Inc. | Oct 1, 2019 | Special |
Clearances by year
27 OCL 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 1 | 23 |
| 2024 | 1 | 242 |
| 2022 | 2 | 132 |
| 2021 | 2 | 93 |
| 2020 | 1 | 93 |
| 2019 | 6 | 85 |
| 2018 | 2 | 59 |
| 2017 | 1 | 29 |
| 2014 | 1 | 89 |
| 2013 | 2 | 77 |
| 2012 | 6 | 75 |
| 2011 | 2 | 128 |
Who submits
5 applicants cleared a OCL device since 2011. 100% of the clearances went to applicants in United States. By type: Special 59% and Traditional 41%.
| Applicant | Clearances since 2011 |
|---|---|
| AtriCure, Inc. | 14 |
| Medtronic, Inc. | 6 |
| Medtronic | 3 |
| Endoscopic Technologies, Inc. D/B/A Estech | 2 |
| Ncontact Surgical, Inc. | 2 |
How FDA classifies it
Class II.
From 21 CFR 878.4400.
Standards
21 CFR 878.4400 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent OCL clearances declared.
Ask about OCL
Questions about OCL
What is FDA product code OCL?
Product code OCL, “Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue” in FDA's classification database, is a Class II device type under 21 CFR 878.4400 (electrosurgical cutting and coagulation device and accessories), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 54 clearances under OCL, 27 of them since 2011.
How many 510(k) clearances are there under OCL?
FDA’s 510(k) database listed 54 clearances under OCL as of Oct 29, 2026, 27 of them decided since 2011; the most recent decision was Jul 24, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a OCL 510(k)?
For the 1 OCL clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 23 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most OCL clearances?
Since 2011: AtriCure, Inc. (14), Medtronic, Inc. (6), Medtronic (3), Endoscopic Technologies, Inc. D/B/A Estech (2) and Ncontact Surgical, Inc. (2). 5 applicants have cleared a OCL device in that time.